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Two flavonols, glyasperin A (1), and meliternatin (2) has been isolated from the leaves of 
Macaranga gigantea (Rchb.f. & Zoll.) Müll.Arg. Extraction and isolation of flavonols were 
used methanol with the maceration method. The process of fractionation and 
purification used column chromatography and radial chromatography. The structure of 
both flavonols was determined by spectroscopic methods, including UV-Vis, IR, 
HRESIMS, 1D NMR (1H, and 13C-NMR) and 2D NMR (HMBC and HMQC). The cytotoxic 
activity of glyasperin A (1), and meliternatin (2) toward P-388 leukemia murine cells by 
MTT method, showing IC50 values 3.44 and 30.04 µg/mL, respectively. 
 




Macaranga (Euphorbiaceae) is 
one of the pioneer plants that are found 
in secondary forests, especially those 
that get lots of suns. The genus 
Macaranga consists of 310 species, and 
in Indonesia, around 140 species are 
found. The spread of this plant is quite 
extensive, covering Africa to the tropical 
regions of Asia to the Pacific region 
(Blattner et al., 2001). This plant is 
widely used by the community as 
traditional medicines, among others, as 
medicine for wounds, infections, 
diarrhea, and coughs (Heyne, 1987). 
Macaranga produces phenolic 
compounds, especially flavonoids 
(Agustina et al., 2012, Tanjung et al., 
2018, 2014) and stilbenoids (Aldin et al., 
2019; Beutler et al., 1998; Tjahjandarie 
et al., 2019). Flavonoids and stilbenoids 
of Macaranga have terpenyl side chains 
PHARMACY: Jurnal Farmasi Indonesia                                                          p-ISSN 1693-3591 
(Pharmaceutical Journal of Indonesia)                                                          e-ISSN 2579-910X 




such as isoprenyl (C5), geranyl (C10), and 
farnesyl (C15), which are attached to the 
aromatic nucleus. Flavonoids and 
stilbenoids of Macaranga show 
bioactivity as antimalarial, antioxidant, 
antimicrobial, anti-inflammatory, and 
anticancer (Pailee et al., 2015; Peresse et 
al., 2017; Magadula et al., 2014). On this 
occasion, two flavonols will be reported, 
namely glyasperin A (1), and 
meliternatin (2) from the ethyl acetate 
extract of Macaranga gigantea (Rchb.f. 
& Zoll.) Müll.Arg. leaves. Phytochemical 
data on this plant is still very limited. It 
will also be reported to test the cytotoxic 
activity of the two flavonols toward P-
388 murine leukemia cells using the MTT 
method. 
 
Material and Methods 
General procedure  
Cerium sulfate reagent is used as 
a stain to show flavonoids compounds. 
Silica gel is used as a stationary phase in 
gravity column chromatography and 
radial chromatography. Thin layer 
chromatography analysis (TLC) using T25 
silica gel 60 GF254 0.25 mm (Merck) TLC 
plates. The UV spectrum was 
determined with a Shimadzu 1800 UV-
Vis spectrophotometer. The IR spectrum 
was determined with the Shimadzu IR 
spectrophotometer. The mass spectrum 
was determined with the HRESIMS 
Merck Waters LCT XE ESI-TOF 
spectrometer, the NMR spectrum was 
determined by the NMR JEOL ECA 400 
spectrophotometer operating at 400 
MHz (1H- NMR) and 100 MHz (13C-NMR). 
Cytotoxic activity test against P-388 
murine leukemia cells was determined 
using the MTT method. 
Plant materials 
Plant samples used in the study 
were M. gigantea leaves. Plant samples 
were obtained from the forest area of 
Jalan Samarinda-Sanga-Sanga, Palaran 
District, Samarinda, East Kalimantan. The 
identification of plant samples was 
carried out at the Bogoriensis 
Herbarium. 
Experiments 
1.  Extraction and isolation 
Extraction of M. gigantea (2.5 
kg) leaves using methanol at room 
temperature for 24 hours three 
times. Evaporation of the solvent 
using a low-pressure device produces 
crude methanol extract. The crude 
methanol extract, partitioned with n-
hexane to remove chlorophyll and 
nonpolar compounds. The methanol 
extract was added with 10% v/v H2O 
and partitioned with ethyl acetate. 
Evaporation of the solvent using a 
low-pressure device produces a crude 
EtOAc extract of 70 g. Separation of 
EtOAc extracts using gravity column 
chromatography using n-hexane: 
EtOAc (9: 1 to 3: 7) produces three 
main fractions, namely the A-C 
fraction. Fractions A and C show the 
presence of flavonoid compounds 
with cerium sulfate reagents 
characterized by brownish-yellow 
spots. The separation of fraction C by 
gravity column chromatography using 
a mixture of n-hexane: EtOAc (8: 2 
and 1: 1) produced three 
subfractions, C1-C3. Separation of C2 
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subfraction from the Sephadex 
column using methanol results in C21-
C23 subfraction. Purification of the C21 
subfraction by radial chromatography 
with a mixture of n-hexane: acetone 
(9: 1 to 7: 3) resulted in 20 mg of 
meliternatin (2). Separation of 
fraction A by gravity column 
chromatography using hexane: EtOAc 
(9: 1 and 7: 3) produces three 
subfractions, namely A1-A3. 
Purification of the A1 subfraction by 
radial chromatography using n-
hexane: CHCl3 (7: 3 to 100% CHCl3) 
produced 45 mg glyasperin A (1) 
compounds. 
2.  Cytotoxic activity   
Determination of the anticancer 
activity test of the flavonols (1-2) was 
determined using the MTT method in 
vitro. Cytotoxic activity of the isolated 
compounds 1-2 to P-388 murine 
leukemia cells was determined 
according to the MTT assay, as 
previously reported (Tanjung et al., 
2018; Tjahjandarie et al., 2020).  
 
Results and Discussion 
The glyasperin A (1) compound 
is the result of isolation in the form of a 
yellow solid with a melting point of 164–
166ºC, showing a quasi-molecular ion 
peak at [M+H]+ m/z 421.6510 consistent 
to a chemical formulation of C25H27O6 by 
high-resolution ESIMS spectrum. 
Glyasperin A (1) in MeOH, showing three 
maxima absorptions at λmax nm (log 
ε) 253 (3.52); 270 (3.51), and 336 (3.58) 
possess of flavonol moiety (Tanjung et 
al., 2009). The IR spectrum of glyasperin 
A (1) in KBr, showing the functional 
group of conjugated carbonyl at 1649 
cm-1, hydroxy at 3350 cm-1, and aromatic 
at1446 to 14502 cm-1, respectively. The 
1H-NMR spectrum of glyasperin A (Table 
1, CDCl3) consists of two units of 
aromatic, a set of isoprenyl protons, and 
four protons of hydroxy. One aromatic 
proton signal in ring A showed at δH 6.47 
(1H, s, H-8) and three aromatic proton 
signals of the ABX system in ring B 
showed at δH 6.93 (IH, d, J = 8.4 Hz, H-
5´), δH 7.99 (1H, dd, J = 8.4 and 2.2 Hz, H-
6´) and δH 8.00 (1H, d, J = 2.2 Hz, H-2´). 
The glyasperin A (1) compound also 
showed the presence of two proton 
units of isoprenyl consisting of two 
vinylic proton signals [δH 5.29 (1H, t, J = 
7.2 Hz, H-2´´) and δH 5.36 (1H, t, J = 7.2 
Hz, H-2´´´)], two methylenes [δH 3.45 
(2H, d, J = 7.8 Hz, H-1´´´) and δH 3.47 (2H, 
d, J = 7.8 Hz, H-1´´), and four methyl 
protons [δH 1.78 (3H, s, H-4´´); δH 1.80 
(3H, s, H-4´´´); δH 1.82 (3H, s, H-5´´), and 
δH 1.85 (3H, s, H-5´´´)]. Four hydroxy 
proton showed at δH 5.58 (1H, s, 4´-OH); 
δH 6.22 (1H, s, 7-OH); δH 6.57(1H, s, 3-
OH), δH 12.12 (1H, s, 5-OH). The 13C-NMR 
spectrum of glyasperin A (Table 1, 
CDCl3), showing 25 carbon peaks that are 
completely separated. One carbonyl 
carbon (δC 175.3) and six oxycarbon 
signals (δC 135.5; δC 145.8; δC 155.1, δC 
156.4; δC 157.8; δC 161.6) indicate 
compound 1 is a kaempferol derivative. 
The HMBC spectrum determined the 
location of the four hydroxy groups and 
two isoprenyl side chains in the 
kaempferol skeleton. The HMBC 
spectrum showed related to a hydroxy 
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proton at δH 12.12 (5-OH) to C-4a (δC 
103.6), C-5 (δC 157.8), and C-6 (δC 109.3). 
The methylene of isoprenyl at δH 3.47 
(H-1´´) related to C-5, C-6, C-7 (δC 161.6), 
C-2´´ (δC 121.1), and C-3´´ (δC 136.3), 
indicating the isoprenyl side chain was 
attached to C-6. A hydroxy proton at δH 
6.22 (7-OH) showed correlations to C-6, 
C-7, and C-8 (δC 94.3), supporting an 
isoprenyl at C-6. An aromatic proton at 
δH 7.99 (H-6´) related to C-3´ (δC 127.1), 
C-4´ (δC 156.4), and C-1´´´ (δC 30.2), and a 
methylene proton at δH 3.45 (H-1´´´) 
related to C-2´ (δC 127.7), C-3´, C-4´, C-
2´´´ (δC 121.3), and C-3´´´ (δC 135.8), 
indicating the others isoprenyl side chain 
was attached to C-3´. Based on the 
above spectroscopic data, the chemical 
structure of the isolated compound is 
glyasperin A (Tanjung et al., 2009). The 
relation between the proton signal and 
the carbon signal, supporting the 
structure of the glyasperin A compound, 
can be seen in Figure 1 and Table 1.
  
Table 1. NMR spectrum of glyasperin A in CDCl3 
No. C δH (mult, J in Hz) δC HMBC 
2 - 145.8 - 
3 - 135.5 - 
4 - 175.3 - 
4a - 103.6 - 
5 - 157.8 - 
6 - 109.3 - 
7 - 161.6 - 
8 6.47 (s) 94.3 C-4a, C-6, C-7, C-8a 
8a - 155.1 - 
1’ - 123.4 - 
2’ 8.00 (d, 2.2) 127.7 C-4’, C-6’ 
3’ - 127.1 - 
4’ - 156.4 - 
5’ 6.93 (d, 8.4) 116.1 C-1’, C-3’ 
6’ 7.99 (dd, 8.4; 2.2) 129.8 C-3’, C-4’ 
1’’ 3.47 (d, 7.8) 21.5 C-5, C-6, C-7, C-2’’, C-3’’ 
2’’ 5.29 (t, 7.2) 121.1 C-1’’, C-4’’, C-5’’ 
3’’ - 136.3 - 
4’’ 1.78 (s) 26.0 C-2’’, C-3’’, C-5’’ 
5’’ 1.82 (s) 18.1 C-2’’, C-3’’, C-4’’ 
1’’’ 3.45 (d, 7.8) 30.2 C-2’, C-3’, C-4’, C-2’’’, C-3’’’ 
2’’’ 5.36 (t, 7.2) 121.3 C-1’’’, C-4’’’, C-5’’’ 
3’’’ - 135.8 - 
4’’’ 1.80 (s) 25.9 C-2’’’, C-3’’’, C-5’’’ 
5’’’ 1.82 (s) 18.0 C-2’’’, C-3’’’, C-4’’’ 
3-OH 6.57 (s) - C-2, C-3, C-4 
5-OH 12.12 (s) - C-4a, C-5, C-6 
7-OH 6.22 (s) - C-6. C-7, C-8 
4’-OH 5.58 (s) - C-3’, C-4’, C-5’ 
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Figure 1. Structures of glyasperin A and meliternatin 
 
The meliternatin (2) compound 
is the result of isolation in the form of a 
yellow solid with a melting point of 196–
197ºC, showing a quasi-molecular ion 
peak at [M+H]+ m/z 371.0769 consistent 
to a chemical formulation of C19H14O8 by 
high-resolution ESIMS spectrum. The UV 
spectrum (λmax nm) (log ε) 247 (4.22); 
270 (4.08) and 336 (4.34), and IR 
spectrum (ν (cm-1): 1641, 1502) alike to 
1. The 1H-NMR spectrum of meliternatin 
(Table 2, CDCl3) consists of two units of 
aromatic, a set of methylenedioxy, and 
two protons of methoxy. An aromatic 
proton in ring A, showing at δH 6.65 (1H, 
s, H-8), and the protons of ABX system in 
ring B, showing at δH 6.91 (IH, d, J = 8.4 
Hz, H-5´), δH 7.63 (1H, dd, J = 8.4 and 1.8 
Hz, H-6´) and δH 7.56  (1H, d, J = 1.8 Hz, 
H-2´). The meliternatin (2) compound 
also showed the presence of a set of 
methylenedioxy [δH 6.04 (2H, s, 6-O-CH2-
O-7) and δH 6.05 (2H, s, 3´-O-CH2-O-4´)], 
and two proton of methoxy [δH 3.86 (3H, 
s, 3-OCH3) and δH 4.12 (3H, s, 5-OCH3)]. 
The 13C-NMR spectrum of meliternatin 
(Table 2, CDCl3), showing 19 carbon 
peaks that are completely separated. 
One carbonyl carbon (δC 174.0) and 
seven oxycarbon signals (δC 134.8, δC 
140.8; δC 141.1; δC 147.9; δC 149.4; δC 
152.6; δC 153.0;) indicate compound 2 is 
a quercetin derivative (Saputri et al., 
2018). The HMBC spectrum determined 
the location of the two methoxy groups 
and two methylenedioxy in the 
quercetin skeleton. The HMBC spectrum 
showed related to an aromatic at δH 6.65 
(H-8) to C-4a (δC 113.1), C-6 (δC 134.8), C-
7 (δC 153.0), and C-8a (δC 153.7). The 
proton of methylenedioxy at δH 6.04 (6-
O-CH2-O-7) related to C-6, and C-7, 
indicating the methylenedioxy was fused 
at C-6, and C-7. An aromatic proton at δH 
7.63 (H-6´) related to C-2 (δC 152.6), C-3´ 
(δC 147.9), C-4´ (δC 149.4), and C-6´ (δC 
123.1), and methylenedioxy proton at δH 
6.05 (3´-O-CH2-O-4´) related to C-3´, and 
C-4´, indicating the others 
methylenedioxy was fused to C-3´, and 
C-4´. Based on the above spectroscopic 
data, the chemical structure of the 
isolated compound is meliternatin 
(Saputri et al., 2018). The relation 
between the proton signal and the 
carbon signal, supporting the structure 
of the meliternatin compound, can be 
seen in Figure 2 and Table 2.
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Figure 2. HMBC selected of glyasperin A and meliternatin 
 
Table 2. NMR spectrum of meliternatin in CDCl3 
No. C δH (mult, J in Hz) δC HMBC 
2 - 152.6 - 
3 - 140.8 - 
4 - 174.0 - 
4a - 113.1 - 
5 - 141.1 - 
6 - 134.8 - 
7 - 153.0 - 
8 6.65 (s) 93.0 C-4a, C-6, C-7, C-8a 
8a - 153.7 - 
1’ - 124.5 - 
2’ 7.56 (d, 1.8) 108.4 C-1’, C-3’, C-4’, C-6’ 
3’ - 147.9 - 
4’ - 149.4 - 
5’ 6.91 (d, 8.4) 108.5 C-1’, C-3’ 
6’ 7.63 (dd, 8.4; 1.8) 123.1 C-2, C-3’, C-4’, C-5’ 
3-OCH3 3.86 (s) 59.9 C-3 
5-OCH3 4.12 (s) 61.3 C-5 
6,7-OCH2-O 6.04 (s) 101.7 C-6, C-7 
3’,4’-OCH2-O 6.05 (s) 102.2 C-3’, C-4’ 
 
 
The cytotoxic activity of 
glyasperin A (1) to P-388 leukemia 
murine cells by MTT method, showing 
moderate activity with IC50 values 3.44 
µg/mL. The meliternatin (2), showing IC50 
values 30.04 µg/mL, and inactive activity. 
 
Conclusion 
Two flavonol derivates, 
glyasperin A and meliternatin, were 
isolated from the leaves of M. gigantea. 
Glyasperin showed moderate activity to 
P-388 cells, meliternatin was inactive. 
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